Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:business_executive
gptkb:scientist biologist |
| gptkbp:almaMater |
gptkb:Columbia_University
|
| gptkbp:awardReceived |
gptkb:Eli_Lilly_Award_in_Biological_Chemistry
National Academy of Sciences member National Inventors Hall of Fame inductee National Academy of Medicine member |
| gptkbp:birthPlace |
gptkb:New_York_City
|
| gptkbp:dateOfBirth |
1959
|
| gptkbp:degree |
gptkb:PhD
MD |
| gptkbp:employer |
gptkb:Regeneron_Pharmaceuticals
|
| gptkbp:ethnicity |
Greek-American
|
| gptkbp:field |
gptkb:biotechnology
genetics immunology |
| gptkbp:founder |
gptkb:Regeneron_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
George Yancopoulos
|
| gptkbp:knownFor |
gptkb:Regeneron_Pharmaceuticals
drug discovery biotechnology innovation |
| gptkbp:nationality |
gptkb:American
|
| gptkbp:notableWork |
development of Dupixent
development of EYLEA development of Praluent |
| gptkbp:occupation |
President
biologist Chief Scientific Officer |
| gptkbp:bfsParent |
gptkb:Regeneron
gptkb:Regeneron_Pharmaceuticals |
| gptkbp:bfsLayer |
6
|